Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourBearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $13.18
Key levels
Resistance$15.66
Resistance$14.26
Support$13.18
Support$12.38
Latest news & SEC filings
AnalystBarclays lifts its target on LifeStance Health Group to $18, up from $15, keeping Overweight
NewsRyan Pardo of LifeStance Health submits Form 144 for share sale
DealLifeStance Health sets terms for 45 million-share resale
DealLifeStance Health Group sets $13.12 per share for 45M share resale
DealLifeStance Health holders offer 45M shares; company to buy back 2M
All LFST news →LifeStance Health runs outpatient mental health clinics and a virtual care platform across the United States. Its licensed clinicians offer psychiatric evaluation and treatment, cognitive and diagnostic assessments, and therapy for individuals, families, and groups. They treat conditions such as anxiety, depression, bipolar disorder, and PTSD. Patients receive care in person at centers or online, mainly through in-network insurance coverage from commercial and government payors. The company also works with primary care and specialist physicians on referrals and integrated care.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
SEPT Low Target
$9.00
SEPT Mid Target
$16.00
SEPT High Target
$20.00
Analyst Consensus
$16.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LFST.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$12.84
35
Moat Score
NONE
7/9
Piotroski Score
5.3
Altman Z-Score
Insider Signal
SELLING
0 buys / 13 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bourdon David | director officer | Sale | 150,000 | - | Sep 22, 2026 |
| Bourdon David | director officer | Sale | 150,000 | - | Sep 2, 2026 |
| DeLuca Teresa | director | Sale | 7,500 | $95K | Aug 14, 2026 |
| DeLuca Teresa | director | Sale | 20,441 | $250K | Aug 13, 2026 |
| Burdick Kenneth A | director | Sale | 500,000 | $5.8M | Aug 11, 2026 |
| TPG GP A, LLC | 10% owner | Sale | 13,643,207 | $144.9M | Aug 10, 2026 |
| Paunovich Vukasin | officer | Sale | 17,456 | $150K | Jun 11, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
13.8%
3yr Revenue CAGR
18.3%
EPS Growth YoY
113.33%
FCF Growth YoY
28.4%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for LFST, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:15:04 | $14.25 | 1,000 | $$14K | SELL |
| 21:42:19 | $14.37 | 87,476 | $$1.3M | SELL |
| 21:12:15 | $14.36 | 10,030 | $$144K | SELL |
| 21:05:00 | $14.37 | 653,671 | $$9.4M | SELL |
| 21:05:00 | $14.37 | 63,648 | $$915K | SELL |
5 dark pool trades shown · $$11.7M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for LFST, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $17 | Mar 19 | 128 | $$1040 | 16 | SWEEP |
| CALL | $14 | Dec 18 | 37 | $$110 | 1 | SWEEP |
| CALL | $14 | Dec 18 | 37 | $$550 | 5 | SWEEP |
| CALL | $14 | Dec 18 | 37 | $$3230 | 34 | SWEEP |
4 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for LifeStance Health Group, Inc. (LFST) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LifeStance Health Group, Inc. (LFST) is at $14.15, down 1.53% (-$0.22) at the Nov 12, 2026 close.
Latest LFST news — Nov 11, 2026: Barclays lifts its target on LifeStance Health Group to $18, up from $15, keeping Overweight · Nov 10, 2026: Ryan Pardo of LifeStance Health submits Form 144 for share sale
LifeStance Health announced a secondary stock sale of 45 million shares by existing holders at a fixed price of $13.12 per share, alongside a concurrent buyback by the company. Despite the potential dilution concerns from the resale, the stock closed at $14.60, up 6.10% on the day, with a trading range of $13.20 to $14.91 on volume of over 27.7 million shares.
The average analyst price target for LFST is $16.00, ranging from $9 to $20, based on 7 analysts. Latest: JP Morgan maintains on Nov 12, 2026.
Analyst ratings for LFST: 0 Buy, 17 Hold, 0 Sell — consensus Hold.
LFST last reported on Nov 5, 2026: EPS $0.06 vs $0.04 expected — a beat of 50.0%.
LFST trades at a P/E of 75.6 vs a Healthcare average of 17.7.
LFST does not currently pay a dividend.
LifeStance Health Group, Inc. reported $272M of debt and $219M of cash (Sep 30, 2026).
Support: $13.18, $12.38, $11.68. Resistance: $14.26, $15.66, $16.63.
Insider activity: SELLING, 0 buys and 13 sells in the last 90 days.
Nov 11, 2026: Barclays lifts its target on LifeStance Health Group to $18, up from $15, keeping Overweight · Nov 10, 2026: Ryan Pardo of LifeStance Health submits Form 144 for share sale · Nov 9, 2026: LifeStance Health sets terms for 45 million-share resale